A detailed history of Hb Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hb Wealth Management, LLC holds 74,493 shares of BMY stock, worth $4.02 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
74,493
Previous 69,801 6.72%
Holding current value
$4.02 Million
Previous $3.79 Million 18.28%
% of portfolio
0.04%
Previous 0.05%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$40.25 - $52.99 $188,853 - $248,629
4,692 Added 6.72%
74,493 $3.09 Million
Q1 2024

Apr 30, 2024

BUY
$47.98 - $54.4 $213,558 - $242,134
4,451 Added 6.81%
69,801 $3.79 Million
Q4 2023

Jan 16, 2024

SELL
$48.48 - $57.85 $165,462 - $197,442
-3,413 Reduced 4.96%
65,350 $3.35 Million
Q3 2023

Oct 13, 2023

BUY
$57.89 - $64.73 $327,136 - $365,789
5,651 Added 8.95%
68,763 $3.99 Million
Q2 2023

Jul 13, 2023

BUY
$63.71 - $70.74 $374,551 - $415,880
5,879 Added 10.27%
63,112 $4.04 Million
Q1 2023

Apr 13, 2023

SELL
$65.71 - $74.53 $123,009 - $139,520
-1,872 Reduced 3.17%
57,233 $3.97 Million
Q4 2022

Jan 20, 2023

BUY
$68.48 - $81.09 $553,934 - $655,937
8,089 Added 15.86%
59,105 $0
Q3 2022

Oct 19, 2022

SELL
$0.13 - $76.84 $207 - $122,790
-1,598 Reduced 3.04%
51,016 $3.63 Million
Q2 2022

Jul 15, 2022

BUY
$72.62 - $79.98 $1.19 Million - $1.31 Million
16,395 Added 45.27%
52,614 $4.05 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $384,618 - $461,192
6,256 Added 20.88%
36,219 $2.65 Million
Q4 2021

Feb 15, 2022

BUY
$53.63 - $62.52 $1.61 Million - $1.87 Million
29,963 New
29,963 $1.87 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hb Wealth Management, LLC Portfolio

Follow Hb Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hb Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hb Wealth Management, LLC with notifications on news.